57 cases of acute leukemia. Trial treatment with a semisynthetic daunorubicin derivative: 22,050 R.P
Bernard, J.; Jacquillat, C.; Boiron, M.; Weil, M.; Gémon, M.F.; Izrael, V.; Schaison, G.; Delobel, J.
La Nouvelle Presse Medicale 1(33): 2149-2152
1972
ISSN/ISBN: 0301-1518 PMID: 4507740 Document Number: 48182
Document emailed within 1 workday
Related Documents
Wiernik, P.H.; Schimpff, S.C.; Schiffer, C.A.; Lichtenfeld, J.L.; Aisner, J.; O'connell, M.J.; Fortner, C. 1976: Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia Cancer Treatment Reports 60(1): 41-53Vogler, W.R.; Velez-Garcia, E.; Omura, G.; Raney, M. 1989: A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia Seminars in Oncology 16(1 Suppl 2: 21-24
Berman, E.; Arlin, Z.A.; Gaynor, J.; Miller, W.; Gee, T.; Kempin, S.J.; Mertelsmann, R.; Andreeff, M.; Reich, L.; Nahmias, N. 1989: Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol Leukemia 3(2): 115-121
Takemoto, Y.; Sampi, K.; Kuraishi, Y.; Okabe, K.; Tamura, K.; Mizoguchi, H.; Saito, H.; Masaoka, T.; Ogawa, M. 1999: A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. the KRN8602 Leukemia Study Group International Journal of Hematology 70(1): 20-25
Arlin, Z.; Case, D.C.; Moore, J.; Wiernik, P.; Feldman, E.; Saletan, S.; Desai, P.; Sia, L.; Cartwright, K. 1990: Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group Leukemia 4(3): 177-183
Mantel, N. 1983: Responder versus nonresponder comparisons: daunorubicin plus prednisone in treatment of acute nonlymphocytic leukemia Cancer Treatment Reports 67(3): 315-316
Schwartsmann, G.; Fernandes, M.S.; Schaan, M.D.; Moschen, M.; Gerhardt, L.M.; Di Leone, L.; Loitzembauer, B.; Kalakun, L. 1997: Decitabine (5-Aza-2'-deoxycytidine; DAC) plus daunorubicin as a first line treatment in patients with acute myeloid leukemia: preliminary observations Leukemia 11(Suppl 1): S28-S31
Stolt, C.M. 1992: A breakthrough for treatment of acute leukemia with a vitamin a acid derivative Lakartidningen 89(18): 1565-1566
Noto, R.; Robert, J.; Hanote, P. 1970: Emergency treatment and transportation of cases of acute imipramine derivative poisoning (apropos of 70 cases) Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 11(6): 515-523
Weil, M.; Glidewell, O.J.; Jacquillat, C.; Levy, R.; Serpick, A.A.; Wiernik, P.H.; Cuttner, J.; Hoogstraten, B.; Wasserman, L.; Ellison, R.R.; Gailani, S.; Brunner, K.; Silver, R.T.; Rege, V.B.; Cooper, M.R.; Lowenstein, L.; Nissen, N.I.; Haurani, F.; Blom, J.; Boiron, M.; Bernard, J.; Holland, J.F. 1973: Daunorubicin in the therapy of acute granulocytic leukemia Cancer Research 33(5): 921-928
Haruyama, H.; Shimazaki, C.; Nakanishi, S.; Hamami, T.; Nisio, A.; Isemura, T.; Katsume, H.; Nakagawa, M.; Ijichi, H. 1982: Cardiotoxicity of daunorubicin and aclacinomycin a in patients with acute leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(3): 516-521
Mandelli, F.; Petti, M.C.; Ardia, A.; Di Pietro, N.; Di Raimondo, F.; Ganzina, F.; Falconi, E.; Geraci, E.; Ladogana, S.; Latagliata, R. 1991: A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia. A multicentric study from the Italian Co-operative Group GIMEMA European Journal of Cancer 27(6): 750-755
Asou, N.; Adachi, K.; Tamura, J.; Kanamaru, A.; Kageyama, S.; Hiraoka, A.; Omoto, E.; Akiyama, H.; Ohno, R. 2000: Treatment of acute promyelocytic leukemia with all-trans retinoic acid and chemotherapy--multicenter trial of the Japan Adult Leukemia Study Group (JALSG) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(8): 1168-1173
Burns, C.P. 1975: Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia Cancer ChemoTherapy Reports 59(4): 757-760
Pagé, M.; Thibeault, D.; Noël, C.; Dumas, L. 1990: Coupling a preactivated daunorubicin derivative to antibody. A new approach Anticancer Research 10(2a): 353-357
Dłuzniewska, A.; Balwierz, W.; Balcerska, A.; Chybicka, A.; Kamieńska, E.; Karolczyk, G.; Karpińska-Derda, I.; Krawczuk-Rybak, M.; Kowalczyk, J.R.; Lewandowska, D.; Maciejka-Kapuścińska, L.; Kołtano, S.; Malinowska, I.; Matysiak, Mł.; Mikołajczyk, M.; Mizia-Malarz, A.; Muszyńska-Rosłan, K.; Niedźwiedzki, M.; Pohorecka, J.; Sikorska-Fic, B.; Sobol, G.; Sońta-Jakimczyk, D.; Tomaszewska, R.; Urasiński, T.; Wachowiak, J.; Wieczorek, M.; Wójcik, B.; Wysocki, M. 2010: Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia Przeglad Lekarski 67(6): 366-370
Taguchi, H.; Kubonishi, I.; Takehara, N.; Uemura, Y.; Iwahara, Y.; Eguchi, T.; Miyagi, T.; Sugito, S.; Muneishi, H.; Tanaka, Y. 1992: Intensive induction chemotherapy of adult acute myelogenous leukemia by continuing daunorubicin, behenoyl-cytosine arabinoside, 6-mercaptopurine and prednisolone until marrow aplasia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(9): 1309-1314
Audebert, A.A.; Zylberait, D.; Krulik, M.; Debray, J. 1979: Headache following intrathecal therapy in acute leukemia: trial of tiapride as a symptomatic treatment La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 55(19-20): 993-997
Liu, Y.; Ke, X-yan.; Ma, J.; Shen, Z-xiang.; Zhang, X-hong.; Du, X.; Zhao, Y-ming.; Lü, J-qiao.; Zhan, Z-min.; Zeng, X-ying.; Xu, X-hua.; Lu, Z-sheng. 2005: Multi-institutional randomized controlled clinical trial on China made 4-demethoxydaunokrubicin (IDA) in the treatment of acute leukemia Zhonghua Zhong Liu Za Zhi 27(12): 750-752
D'auteuil, P.; Harel, P. 1976: Treatment of acute myeloid leukemia with daunomycin (38 cases) L'Union Medicale du Canada 105(2): 205-210